State GA
Clinical Trials in Georgia
Recruiting clinical trials with at least one study location in Georgia. Data updated daily from ClinicalTrials.gov.
Top Conditions in Georgia
NCT06267729 Phase 1, Phase 2
Recruiting
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Condition
Metastatic Prostate Cancer
Enrollment
60 pts
Location
United States, Australia, Spain
Sponsor
AstraZeneca
NCT05570253 Phase 2
Recruiting
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
Condition
Breast Cancer
Enrollment
55 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT07321886 Phase 3
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight ...
Condition
Obesity
Enrollment
1,980 pts
Location
United States, Argentina, Australia
Sponsor
Eli Lilly and Company
NCT06961370 Phase 1
Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodyna...
Condition
Geographic Atrophy
Enrollment
132 pts
Location
United States
Sponsor
Hoffmann-La Roche
NCT06238622 Phase 3
Recruiting
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With ...
Condition
Idiopathic Pulmonary Fibrosis
Enrollment
1,700 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT05987241 Phase 2, Phase 3
Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the ...
Condition
Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
992 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT04380740 Phase 2
Recruiting
Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxi...
Condition
Graft Vs Host Disease
Enrollment
160 pts
Location
United States
Sponsor
Boston Children's Hospital
NCT04254185 N/A
Recruiting
Clinical Trial for Surgery of the Ulnar Nerve (SUN) at the Elbow
Condition
Neuropathy Ulnar
Enrollment
378 pts
Location
United States
Sponsor
University of Michigan
NCT06742723 Phase 3
Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the...
Condition
Chronic Kidney Disease and Hypertension
Enrollment
5,000 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT07124910 Phase 3
Recruiting
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute ...
Condition
Keratoconus
Enrollment
485 pts
Location
United States
Sponsor
Woolfson Eye Institute
NCT06296186 N/A
Recruiting
Massed Prolonged Exposure for PTSD in Substance Use Treatment
Condition
Stress Disorders, Post-Traumatic
Enrollment
200 pts
Location
United States
Sponsor
Veterans Medical Research Foun
NCT00567073 N/A
Recruiting
Pompe Pregnancy Sub-Registry
Condition
Glycogen Storage Disease Type II (GSD-II)
Enrollment
20 pts
Location
United States, Belgium, Croatia
Sponsor
Genzyme, a Sanofi Company
NCT06223360 Phase 2
Recruiting
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Ear...
Condition
Alzheimer Disease
Enrollment
406 pts
Location
United States
Sponsor
Alzheimer's Disease Cooperativ
NCT06309979 N/A
Recruiting
A Study to Assess Growth in Children With Idiopathic Short Stature
Condition
Idiopathic Short Stature
Enrollment
300 pts
Location
United States
Sponsor
BioMarin Pharmaceutical
NCT06770582 Phase 2
Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Ther...
Condition
Non-Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
160 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05100862 Phase 3
Recruiting
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Par...
Condition
Relapsed/Refractory Follicular Lymphoma
Enrollment
780 pts
Location
United States, Argentina, Australia
Sponsor
BeiGene
NCT07158242 Phase 3
Recruiting
A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7...
Condition
Moderately to Severely Active Ulcerative Colitis
Enrollment
100 pts
Location
United States, Taiwan, United Kingdom
Sponsor
Hoffmann-La Roche
NCT05983185 N/A
Recruiting
Prism Adaptation Therapy (PAT) for Right Brain Stroke Rehabilitation
Condition
Spatial Neglect After Right Brain Stroke
Enrollment
244 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT05504291 Phase 2
Recruiting
A Study to Give Treatment Inside the Eye to Treat Retinoblastoma
Condition
Bilateral Retinoblastoma
Enrollment
26 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06369298 Phase 2
Recruiting
Study of JK07 in Patients With Chronic Heart Failure
Condition
Heart Failure With Reduced Ejection Fraction
Enrollment
282 pts
Location
United States, Canada, China
Sponsor
Salubris Biotherapeutics Inc
NCT05915299 N/A
Recruiting
US National OCS Heart Perfusion (OHP) Registry
Condition
Heart Transplant
Enrollment
100,000 pts
Location
United States
Sponsor
TransMedics
NCT06741228 Phase 3
Recruiting
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)
Condition
Generalized Anxiety Disorder
Enrollment
200 pts
Location
United States
Sponsor
Definium Therapeutics US, Inc.
NCT04862468 Phase 2
Recruiting
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thro...
Condition
Thrombosis, Deep Vein
Enrollment
80 pts
Location
United States, Ireland, United Kingdom
Sponsor
Mercator MedSystems, Inc.
NCT05983250 Phase 3
Recruiting
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
Condition
Pulmonary Hypertension
Enrollment
230 pts
Location
United States, Canada
Sponsor
Tenax Therapeutics, Inc.